MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
AVTR stock logo

AVTR

Avantor, Inc.

$7.9
0.13
 (1.67%)
Exchange:  NYSE
Market Cap:  5.388B
Shares Outstanding:  650.9M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Instruments & Supplies
   
CEO:  Emmanuel Ligner
Full Time Employees:  13500
Address: 
Radnor Corporate Center
Radnor
PA
19087
US
Website:  https://www.avantorsciences.com
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

Click to read more…

Revenue Segmentation

MARKETSnap
MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/02/11 — 4 quarter 2025

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

🔒 You are currently logged out

Login

It's free

(* All numbers are in thousands)

Balance Sheet

🔒 You are currently logged out

Login

It's free

(* All numbers are in thousands)

Cash Flow Statement

🔒 You are currently logged out

Login

It's free

(* All numbers are in thousands)

Analyst Estimates

🔒 You are currently logged out

Login

It's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
6.784B  ?P/S
 (TTM)
: 
0.89
?Net Income
 (TTM)
: 
711.5M  ?P/E
 (TTM)
: 
-10.9
?Enterprise Value
 (TTM)
: 
9.392B  ?EV/FCF
 (TTM)
: 
18.97
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-0.09  ?ROIC
 (TTM)
: 
-0.02
?Net Debt
 (TTM)
: 
3.967B  ?Debt/Equity
 (TTM)
: 
0.71
?P/B
 (TTM)
: 
1.04  ?Current Ratio
 (TTM)
: 
1.78

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
10.00Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

Strengths (preview)
  • Solid Revenue Performance: Avantor reported a third-quarter 2025 revenue of $1.62 billion, reflecting consistent topline results as highlighted in the latest earnings call. This performance underscores the company’s ability to maintain revenue streams in the life sciences sector.
  • Strong Brand Portfolio: The earnings call emphasized Avantor’s robust brand presence in life sciences, which supports customer loyalty and market positioning within a competitive industry.
  • Operational Stability: Key metrics such as currentRatioTTM and quickRatioTTM (specific values to be derived from data) indicate adequate liquidity to meet short-term obligations, providing a stable financial foundation as per the latest balance sheet data.

Log in with Full Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Full Access for the complete SWOT analysis.

Login — it's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates AVTR intrinsic value between $14.60 – $14.93 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate AVTR Intrinsic Value

Common questions about AVTR valuation

Is Avantor, Inc. (AVTR) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for Avantor, Inc. (AVTR) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is AVTR a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether AVTR trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is AVTR’s P/E ratio?

You can see AVTR’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for AVTR?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is AVTR a good long-term investment?

Whether AVTR fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

AVTR

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1.67
MARKETSnap

Trading Metrics:

Open: 7.63   Previous Close: 7.77
Day Low: 7.59   Day High: 8.07
Year Low: 7.27   Year High: 16.17
Price Avg 50: 9.16   Price Avg 200: 11.75
Volume: 5.095M   Average Volume: 11.047M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free

AVTR full analysis

10/11/2025

Welcome to MARKETSNAP’s SWOT analysis for Avantor, a key player in the life sciences and advanced technology space. If you’re not familiar with Avantor, let me give you the quick rundown. This company is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education, and advanced tech industries. They’re deeply embedded in the life sciences sector, supporting everything from research to production with their extensive portfolio. Headquartered in the U.S., Avantor operates on a…

Listen to full analysis (audio file)

Open in MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Login — it's free

See in Nexus

Relevant news

Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer
23-04-2026 17:05
Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer
Avantor Expands Masterflex Portfolio to Streamline Bioprocessing
22-04-2026 13:41
Avantor Expands Masterflex Portfolio to Streamline Bioprocessing
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
22-04-2026 09:32
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
03-04-2026 08:05
Avantor® to Report First Quarter 2026 Earnings on Wednesday, April 29, 2026
Why Is Avantor (AVTR) Down 13.6% Since Last Earnings Report?
13-03-2026 12:30
Why Is Avantor (AVTR) Down 13.6% Since Last Earnings Report?
Avantor: The Q4 Dip Could Have Priced In All The Negatives
24-02-2026 12:32
Avantor: The Q4 Dip Could Have Priced In All The Negatives

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read